Bausch+Lomb IPO Presentation Deck
Invested -$2.1B in all areas of B+L since 20181
Diversified portfolio with tailored strategic investments specific to needs of each business
~$60M
Strategic Alliance /
Partnerships
BAUSCH+ LOMB
-$300M -$727M -$1.0B $2.1B
R&D
Product
Capital
Launch Costs Expenditures
1. Investment reflects FY 2018-FY 2021 period
Total Investment
Since 2018
FINANCIAL
PERFORMANCE
Invested in robust R&D capabilities in Surgical business
to drive innovation and continue to shift portfolio to
premium category
Made significant capital expenditure investments in
Vision Care to increase contact lens manufacturing
capacity to support increasing demand and launch daily
SiHy
Invested in launch products, including key Vision Care
products LUMIFYⓇ and INFUSEⓇ
Invested in strategic alliances / partnerships to create
transformational growth opportunity in Ophthalmic
Pharmaceuticals segment and accelerate commercial
efficiencies
41View entire presentation